Tech Company Financing Transactions

Revascular Therapeutics Funding Round

Adams Harkness Ventures, BioStar Private Equity Fund and CLS joined a $4 million funding round for Revascular Therapeutics. The round was announced on 6/30/2006.

Transaction Overview

Announced On
6/30/2006
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
766 Palomar Ave
Sunnyvale, CA 94085
USA
Website
Email Address
Not Recorded
Overview
The company is developing a device system for treatment of total occlusions in arteries.
Profile
Revascular Therapeutics LinkedIn Company Profile
Social Media
Revascular Therapeutics Company Twitter Account
Company News
Revascular Therapeutics News
Facebook
Revascular Therapeutics on Facebook
YouTube
Revascular Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Tom Palermo
  Tom Palermo LinkedIn Profile  Tom Palermo Twitter Account  Tom Palermo News  Tom Palermo on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2006: TagWorld venture capital transaction
Next: 6/30/2006: Acureon Pharmaceuticals venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record tech company VC transactions. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary